David Davis

Dr. David Davis

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2001 in Blood
Verified
Journal Article
Closed access
DDDavid Davis
David Davis
ARAndrea S. Rinderknecht
Andrea S. Rinderknecht
JZJ. Paul Zoeteweij
J. Paul Zoeteweij
YAYoshiyasu Aoki
Yoshiyasu Aoki
ERElizabeth L. Read-Connole
Elizabeth L. Read-Connole
RYRobert Yarchoan
Robert Yarchoan
There is substantial evidence that Kaposi sarcoma–associated herpesvirus (KSHV) plays an important role in the pathogenesis of all forms of Kaposi sarcoma (KS). It has been noted that KS commonly occurs in locations, such as the feet, where tissue may be poorly oxygenated. On the basis of this observation, the potential role of hypoxia in the reactivation of KSHV replication was explored by studying 2 KSHV-infected primary effusion lymphoma B-cell lines (BC-3 and BCBL-1) latently infected with KSHV. Acute and chronic exposure of these cells to hypoxia (1% O2) induced KSHV lytic replication, as indicated by an increase in intracellular lytic protein expression and detection of virus in cell supernatants by Western immunoblotting. In addition, hypoxia increased the levels of secreted viral interleukin-6. Moreover, hypoxia enhanced the lytic replication initiated by the viral inducer 12-O-tetradecanoylphorbol-13-acetate. Desferoxamine and cobalt chloride, 2 compounds that increase the intracellular levels of hypoxia-inducible factor 1, were also able to induce KSHV lytic replication. These studies suggest that hypoxia is an inducer of KSHV replication. This process may play an important role in the pathogenesis of KS.

12 February 2010 in Implementation Science
Verified
Journal Article
Open access
PDF file
KMK Ann McKibbon
K Ann McKibbon
CLCynthia Lokker
Cynthia Lokker
NWNancy L Wilczynski
Nancy L Wilczynski
DCDonna Ciliska
Donna Ciliska
MDMaureen Dobbins
Maureen Dobbins
SSSharon E Straus
Sharon E Straus
The study of implementing research findings into practice is rapidly growing and has acquired many competing names (e.g., dissemination, uptake, utilization, translation) and contributing disciplines. The use of multiple terms across disciplines pose barriers to communication and progress for applying research findings. We sought to establish an inventory of terms describing this field and how often authors use them in a collection of health literature published in 2006. We refer to this field as knowledge translation (KT). Terms describing aspects of KT and their definitions were collected from literature, the internet, reports, textbooks, and contact with experts. We compiled a database of KT and other articles by reading 12 healthcare journals representing multiple disciplines. All articles published in these journals in 2006 were categorized as being KT or not. The KT articles (all KT) were further categorized, if possible, for whether they described KT projects or implementations (KT application articles), or presented the theoretical basis, models, tools, methods, or techniques of KT (KT theory articles). Accuracy was checked using duplicate reading. Custom designed software determined how often KT terms were used in the titles and abstracts of articles categorized as being KT. A total of 2,603 articles were assessed, and 581 were identified as KT articles. Of these, 201 described KT applications, and 153 included KT theory. Of the 100 KT terms collected, 46 were used by the authors in the titles or abstracts of articles categorized as being KT. For all 581 KT articles, eight terms or term variations used by authors were highly discriminating for separating KT and non-KT articles (p < 0.001): implementation, adoption, quality improvement, dissemination, complex intervention (with multiple endings), implementation (within three words of) research, and complex intervention. More KT terms were associated with KT application articles (n = 13) and KT theory articles (n = 18). We collected 100 terms describing KT research. Authors used 46 of them in titles and abstracts of KT articles. Of these, approximately half discriminated between KT and non-KT articles. Thus, the need for consolidation and consistent use of fewer terms related to KT research is evident.

1 March 2009 in Chest
Verified
Journal Article
Closed access
PDF file
DDDavid Davis
David Davis
RGRobert Galbraith
Robert Galbraith
ACAmerican College of Chest Physicians Health and Science Policy Committee
American College of Chest Physicians Health and Science Policy Committee

15 June 2005 in Blood
Verified
Journal Article
Closed access
PDF file
DDDavid Davis
David Davis
KSKathleen E. Singer
Kathleen E. Singer
MSMaria De La Luz Sierra
Maria De La Luz Sierra
MNMasashi Narazaki
Masashi Narazaki
FYFuquan Yang
Fuquan Yang
GTGiovanna Tosato
Giovanna Tosato
The chemokine stromal-derived factor-1α (SDF-1α) is an essential regulator of hematopoiesis, lymphocyte homing, pre-B-cell growth, and angiogenesis. As SDF-1α is constitutively expressed in many tissues, chemokine function is mostly regulated by proteolytic degradation. Human serum cleaves the 68-amino acid chemokine, SDF-1α, at both termini. The enzyme or enzymes responsible for the removal of the carboxy-terminal lysine from SDF-1α, leading to significant reduction in biologic activity, have not been identified. Using a new biochemical assay for measuring the carboxy-terminal cleavage activity, we purified from serum and plasma a peptidase that specifically removes the carboxy-terminal lysine from SDF-1α and identified it as carboxypeptidase N (CPN, also known as kininase I, arginine carboxypeptidase, and anaphylotoxin inactivator). We demonstrate that SDF-1α in serum and plasma lacks the carboxy terminal lysine, and depletion of CPN from serum and plasma significantly reduces the SDF-1α carboxypeptidase activity. Purified CPN effectively and specifically removes the carboxy-terminal lysine from SDF-1α and significantly reduces the chemokine's biologic activity as a pre-B-cell growth factor and chemoattractant. Thus, in addition to its role as a regulator of the biologic activity of kinins and anaphylatoxins, CPN is an important regulator of the biologic activity of SDF-1α by reducing the chemokine-specific activity. (Blood. 2005;105:4561-4568)

14 October 2010 in Implementation Science
Verified
Journal Article
Open access
PDF file
NSNancy M Salbach
Nancy M Salbach
SGSara Jt Guilcher
Sara Jt Guilcher
SJSusan B Jaglal
Susan B Jaglal
DDDavid Davis
David Davis
Despite evidence of the benefits of research use in post-acute stroke rehabilitation where compliance with clinical practice guidelines has been associated with functional recovery and patient satisfaction, the rate of reliance on the research literature in clinical decision making among physical therapists is low. More research examining factors that motivate physical therapists to consider research findings in neurological practice is needed to inform efforts to intervene. The objective of this study was to identify practitioner, organizational, and research characteristics associated with research use among physical therapists providing services post-stroke.

1 May 1997 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
DDDavid Davis
David Davis
RHRachel W. Humphrey
Rachel W. Humphrey
FNFonda M. Newcomb
Fonda M. Newcomb
TOThomas R. O'Brien
Thomas R. O'Brien
JGJames J. Goedert
James J. Goedert
RYRobert Yarchoan
Robert Yarchoan
Kaposi's sarcoma (KS)—associated herpesvirus/human herpesvirus type 8 (KSHV/HHV-8) may play an etiologic role in the pathogenesis of KS. In an attempt to assess KSHV/HHV-8 infection, an ELISA was developed using an 18-amino acid peptide from a putative minor capsid protein of KSHV/HHV—8 conjugated to bovine serum albumin. Overall, sera from human immunodeficiency virus type 1 (HIV-l)—positive patients with KS had a higher reactivity in the assay than did sera from HIV-1—positive patients without KS (P = .018). Of 35 HIV-1—positive patients with KS, 60% were antibody positive, compared with 27% of 33 HIV-1—positive patients without KS. Of 30 healthy blood donors, 20% were antibody positive. The ELISA responses did not correlate with antibody titers to Epstein-Barr virus. Given the homology and antigenic relatedness between KSHV/HHV-8 and Epstein-Barr virus, serologic assays involving unique KSHV/HHV-8 peptides may prove to be valuable in defining the epidemiology and clinical expression of this virus.